Your browser doesn't support javascript.
loading
Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2.
Bauer, Martin; Jorda, Anselm; Al-Jalali, Valentin; Wölfl-Duchek, Michael; Bergmann, Felix; Nussbaumer-Pröll, Alina; Steindl, Ariane; Gugenberger, Romana; Bischof, Sarah; Wimmer, Doris; Idzko, Marco; Zeitlinger, Markus.
Afiliação
  • Bauer M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Jorda A; M. Bauer and M. Zeitlinger contributed equally to this article as lead authors and supervised the work.
  • Al-Jalali V; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Wölfl-Duchek M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Bergmann F; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Nussbaumer-Pröll A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Steindl A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Gugenberger R; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Bischof S; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Wimmer D; APEIRON Respiratory Therapies GmbH, Vienna, Austria.
  • Idzko M; APEIRON Respiratory Therapies GmbH, Vienna, Austria.
  • Zeitlinger M; APEIRON Respiratory Therapies GmbH, Vienna, Austria.
ERJ Open Res ; 10(1)2024 Jan.
Article em En | MEDLINE | ID: mdl-38375429
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article